These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 3149952
1. Synthesis, biological activity and conformational analysis of cyclic GRF analogs. Felix AM, Heimer EP, Wang CT, Lambros TJ, Fournier A, Mowles TF, Maines S, Campbell RM, Wegrzynski BB, Toome V. Int J Pept Protein Res; 1988 Dec; 32(6):441-54. PubMed ID: 3149952 [Abstract] [Full Text] [Related]
7. Pegylated peptides. V. Carboxy-terminal PEGylated analogs of growth hormone-releasing factor (GRF) display enhanced duration of biological activity in vivo. Campbell RM, Heimer EP, Ahmad M, Eisenbeis HG, Lambros TJ, Lee Y, Miller RW, Stricker PR, Felix AM. J Pept Res; 1997 Jun; 49(6):527-37. PubMed ID: 9266480 [Abstract] [Full Text] [Related]
8. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs. Felix AM, Lu YA, Campbell RM. Int J Pept Protein Res; 1995 Jun; 46(3-4):253-64. PubMed ID: 8537179 [Abstract] [Full Text] [Related]
11. Solution structures of cyclic and dicyclic analogues of growth hormone releasing factor as determined by two-dimensional NMR and CD spectroscopies and constrained molecular dynamics. Fry DC, Madison VS, Greeley DN, Felix AM, Heimer EP, Frohman L, Campbell RM, Mowles TF, Toome V, Wegrzynski BB. Biopolymers; 1992 Jun 26; 32(6):649-66. PubMed ID: 1643268 [Abstract] [Full Text] [Related]
12. Position 2 and position 2/Ala15-substituted analogs of bovine growth hormone-releasing factor (bGRF) with enhanced metabolic stability and improved in vivo bioactivity. Kubiak TM, Friedman AR, Martin RA, Ichhpurani AK, Alaniz GR, Claflin WH, Goodwin MC, Cleary DL, Kelly CR, Hillman RM. J Med Chem; 1993 Apr 02; 36(7):888-97. PubMed ID: 8464043 [Abstract] [Full Text] [Related]
13. Solution conformation of Leu27 hGRF(1-32)NH2 and its deamidation products by 2D NMR. Stevenson CL, Donlan ME, Friedman AR, Borchardt RT. Int J Pept Protein Res; 1993 Jul 02; 42(1):24-32. PubMed ID: 8370640 [Abstract] [Full Text] [Related]
14. Potent agonists of growth hormone-releasing hormone. Part I. Zarandi M, Serfozo P, Zsigo J, Bokser L, Janaky T, Olsen DB, Bajusz S, Schally AV. Int J Pept Protein Res; 1992 Mar 02; 39(3):211-7. PubMed ID: 1399259 [Abstract] [Full Text] [Related]
15. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor. Bongers J, Heimer EP, Lambros T, Pan YC, Campbell RM, Felix AM. Int J Pept Protein Res; 1992 Apr 02; 39(4):364-74. PubMed ID: 1428526 [Abstract] [Full Text] [Related]
16. 1H NMR analysis and in vitro bioactivity of Leu27-bGRF(1-29)NH2 and its D-Ala2 and des-(Tyr1-Ala2)-analogs. Kloosterman DA, Scahill TA, Hillman RM, Cleary DL, Kubiak TM. Pept Res; 1991 Apr 02; 4(2):72-8. PubMed ID: 1667740 [Abstract] [Full Text] [Related]
17. Effect of secondary structure on the rate of deamidation of several growth hormone releasing factor analogs. Stevenson CL, Friedman AR, Kubiak TM, Donlan ME, Borchardt RT. Int J Pept Protein Res; 1993 Dec 02; 42(6):497-503. PubMed ID: 8307680 [Abstract] [Full Text] [Related]
18. Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells. Coy DH, Hocart SJ, Murphy WA. Eur J Pharmacol; 1991 Nov 05; 204(2):179-85. PubMed ID: 1806385 [Abstract] [Full Text] [Related]